Spinal Cord Neoplasms: Clinical Trials

2 trials for Spinal Cord Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 12Completed 1, Terminated 1

Follow Spinal Cord Neoplasms: new trials by email Literature Review of Spinal Cord Neoplasms trials Research Report on Spinal Cord Neoplasms

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Combined Decompressive Spine Radiosurgery and Pembrolizumab
Pembrolizumab, Stereotactic Body Radiation Therapy, Blood draws - Epidural Spinal Tumors, Cancer
Early Phase 1TerminatedWake Forest University Health Sciences12022-03-282026-06-29
Donepezil in Treating Young Patients With Primary Brain Tumors Previously Treated With Radiation Therapy to the Brain
Donepezil - Brain and Central Nervous System Tumors, Cognitive/Functional Effects
Early Phase 1CompletedWake Forest University Health Sciences142006-06-012018-09-07

Narrower conditions

Astrocytoma (1)  ·  Central Nervous System Neoplasms (1)  ·  Choroid Plexus Neoplasms (1)  ·  Epidural Neoplasms (1)  ·  Familial ependymoma (1)  ·  Medulloblastoma (1)  ·  Neoplasms (1)  ·  Neurotoxicity Syndromes (1)  ·  Optic Nerve Glioma (1)  ·  Radiation Injuries (1)

Broader conditions

Central Nervous System Diseases (2)  ·  Neoplasms by Site (2)  ·  Nervous System Diseases (2)  ·  Nervous System Neoplasms (2)  ·  Spinal Cord Diseases (2)  ·  Brain Diseases (1)  ·  Brain Neoplasms (1)  ·  Central Nervous System Neoplasms (1)  ·  Cerebral Ventricle Neoplasms (1)  ·  Chemically-Induced Disorders (1)  ·  Cranial Nerve Diseases (1)  ·  Cranial Nerve Neoplasms (1)  ·  Eye Diseases (1)  ·  Glioma (1)  ·  Neoplasms (1)

Interventions

Blood Specimen Collection (1)  ·  Donepezil (1)  ·  Radiosurgery (1)  ·  pembrolizumab (1)

Sponsors

Wake Forest University Health Sciences (2)

Countries

United States (2)

Top investigators

Christina K Cramer, MD (1)  ·  Sharon M. Castellino, MD, FAAP (1)

NIH funding

P30CA012197 (2)